Clinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read More
Clinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read More
Clinically Speaking: Cardiodiabesity 101
More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...
Read More
Addressing Fertility Care Needs
There are steps plan sponsors can take to address reproductive health care needs, including fertility care.
Read More
Addressing Contraceptive Care Needs
There are steps plan sponsors can take to address reproductive health care needs, beginning with contraceptive care.
Read More
Clinically Speaking: Behavioral Health Services in America
92% of adults living with a behavioral health condition also struggle with a physical condition, costing billions annually. We detail strategies to overcome the barriers that keep individuals from see...
Read More